Skip to Main Content

Paper Details

Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features.
Arthritis Rheumatol
44
2017
B lymphocyte stimulator, Connective Tissue Disease, Participants, Patients, SCF, SLE, Systemic Lupus Erythematosus, Systemic lupus erythematosus, TGF, autoimmune diseases, interferon, interleukin-10, lupus, patients, stem, stem cell, transforming growth factor
Author NameAffiliation
Kendra A YoungColorado School of Public Health
Joel M GuthridgeOklahoma Medical Research Foundation
Karen H CostenbaderBrigham and Women's Hospital
David R KarpUniversity of Texas Southwestern Medical Center
John B HarleyCincinnati Children's Hospital Medical Center and US Department of Veterans Affairs Medical Center
Jill M NorrisColorado School of Public Health
  • 1 - 6

Datasets

Release 1.2